Humana Inc. (HUM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Humana Inc.

    NYSE: HUM · Real-Time Price · USD
    283.62
    27.00 (10.52%)
    At close: Oct 03, 2025, 3:59 PM
    283.50
    -0.04%
    After-hours: Oct 03, 2025, 07:59 PM EDT

    Humana Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 32.39B 32.11B 29.21B 29.4B 29.54B 29.61B 26.46B 26.42B 26.75B 26.74B 22.44B 22.8B 23.66B 23.97B 21.05B 20.7B 20.64B 20.67B
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 32.39B 32.11B 29.21B 29.4B 29.54B 29.61B 26.46B 26.42B 26.75B 26.74B 22.44B 22.8B 23.66B 23.97B 21.05B 20.7B 20.64B 20.67B
    Operating Income
    		 741M 1.69B -862M 651M 918M 1.01B -591M 1.1B 1.26B 1.61B -71M 1.3B 1.12B 1.22B -60M 1.64B 738M 1.04B
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 741M 1.69B -862M 651M 918M 1.01B -591M 1.1B 1.26B 1.61B -71M 1.3B 1.12B 1.22B -60M 1.64B 738M 1.04B
    Net Income
    		 545M 1.24B -693M 480M 679M 741M -541M 832M 959M 1.24B -15M 1.2B 696M 930M -14M 1.53B 588M 828M
    Selling & General & Admin
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.6B 2.12B 2.01B
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 31.65B 30.42B 30.07B 28.75B 28.62B 28.6B 27.05B 25.32B 25.48B 25.13B 22.51B 21.5B 22.54B 22.75B 21.11B 16.46B 17.79B 17.62B
    Operating Expenses
    		 31.65B 30.42B 30.07B 28.75B 28.62B 28.6B 27.05B 25.32B 25.48B 25.13B 22.51B 21.5B 22.54B 22.75B 21.11B 19.06B 19.91B 19.63B
    Interest Expense
    		 157M 160M 164M 169M 168M 159M 146M 114M 120M 113M 108M 102M 101M 90M 91M 88M 79M 68M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 31.65B 30.42B 30.07B 28.75B 28.62B 28.6B 27.05B 25.32B 25.48B 25.13B 22.51B 21.5B 22.54B 22.75B 21.11B 19.06B 19.91B 19.63B
    Income Tax Expense
    		 179M 406M -216M 155M 223M 251M -75M 256M 296M 359M -58M 107M 427M 286M -51M 120M 183M 233M
    Shares Outstanding (Basic)
    		 120.54M 120.41M 120.41M 120.41M 120.44M 120.98M 122.46M 123.43M 124.57M 125M 125.64M 126.57M 126.52M 126.94M 128.61M 128.52M 128.69M 128.93M
    Shares Outstanding (Diluted)
    		 120.75M 120.76M 120.76M 120.76M 120.67M 121.27M 122.46M 123.98M 125.11M 125.56M 125.64M 127.36M 127.08M 127.47M 128.61M 129.25M 129.39M 129.55M
    EPS (Basic)
    		 4.52 10.31 -5.75 3.99 5.64 6.13 -4.42 6.74 7.70 9.91 -0.12 9.44 5.50 7.33 -0.11 11.91 4.57 6.42
    EPS (Diluted)
    		 4.51 10.30 -5.76 3.98 5.63 6.11 -4.42 6.71 7.66 9.87 -0.12 9.39 5.48 7.29 -0.11 11.84 4.55 6.39
    EBITDA
    		 1.11B 2.07B -458M 1.06B 1.33B 1.42B -207M 1.45B 1.61B 1.95B 254M 1.61B 1.43B 1.51B 225M 1.91B 987M 1.28B
    EBIT
    		 898M 1.85B -698M 820M 1.09B 1.17B -445M 1.21B 1.38B 1.73B 37M 1.4B 1.22B 1.31B 31M 1.72B 817M 1.11B
    Depreciation & Amortization
    		 211M 215M 240M 243M 243M 242M 238M 235M 226M 218M 217M 214M 209M 205M 194M 181M 170M 168M

    Add to Watchlist